LBA-002Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. (2nd July 2019) - Tabernero, J; Van Cutsem, E; Bang, Y; Fuchs, C; Wyrwicz, L; Lee, K; Kudaba, I; Garrido, M; Chung, H; Castro Salguero, H; Mansoor, W; Braghiroli, M; et al.